Literature DB >> 16312004

Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates.

Elizabeth Hillard1, Anne Vessières, Laurent Thouin, Gérard Jaouen, Christian Amatore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16312004     DOI： 10.1002/anie.200502925

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  33 in total

Review 1.  Redox activation of metal-based prodrugs as a strategy for drug delivery.

Authors:  Nora Graf; Stephen J Lippard
Journal:  Adv Drug Deliv Rev       Date:  2012-01-25       Impact factor: 15.470

2.  Similar biological activities of two isostructural ruthenium and osmium complexes.

Authors:  Jasna Maksimoska; Douglas S Williams; G Ekin Atilla-Gokcumen; Keiran S M Smalley; Patrick J Carroll; Richard D Webster; Panagis Filippakopoulos; Stefan Knapp; Meenhard Herlyn; Eric Meggers
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

3.  New 1,1'-Ferrocene Bis(sulfonyl) Reagents.

Authors:  Kullapa Chanawanno; Cole Holstrom; Victor N Nemykin; Richard S Herrick; Christopher J Ziegler
Journal:  ChemistrySelect       Date:  2016-12-01       Impact factor: 2.109

Review 4.  Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises.

Authors:  Nikolaos Garmpis; Christos Damaskos; Anna Garmpi; Emmanouil Kalampokas; Theodoros Kalampokas; Eleftherios Spartalis; Afrodite Daskalopoulou; Serena Valsami; Michael Kontos; Afroditi Nonni; Konstantinos Kontzoglou; Despina Perrea; Nikolaos Nikiteas; Dimitrios Dimitroulis
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

5.  The synthesis and structures of 1,1'-bis(sulfonyl)ferrocene derivatives.

Authors:  Kullapa Chanawanno; Cole Holstrom; Laura A Crandall; Henry Dodge; Victor N Nemykin; Richard S Herrick; Christopher J Ziegler
Journal:  Dalton Trans       Date:  2016-08-19       Impact factor: 4.390

Review 6.  Nanotherapeutic systems for local treatment of brain tumors.

Authors:  Rami Walid Chakroun; Pengcheng Zhang; Ran Lin; Paula Schiapparelli; Alfredo Quinones-Hinojosa; Honggang Cui
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-05-24

7.  Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.

Authors:  Emilie Allard; Delphine Jarnet; Anne Vessières; Sandrine Vinchon-Petit; Gérard Jaouen; Jean-Pierre Benoit; Catherine Passirani
Journal:  Pharm Res       Date:  2009-11-12       Impact factor: 4.200

8.  ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.

Authors:  Xiaohua Peng; Varsha Gandhi
Journal:  Ther Deliv       Date:  2012-07

9.  Antioxidative activity of ferrocenes bearing 2,6-di-tert-butylphenol moieties.

Authors:  E R Milaeva; S I Filimonova; N N Meleshonkova; L G Dubova; E F Shevtsova; S O Bachurin; N S Zefirov
Journal:  Bioinorg Chem Appl       Date:  2010-06-09       Impact factor: 7.778

Review 10.  Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs.

Authors:  Sabine H van Rijt; Peter J Sadler
Journal:  Drug Discov Today       Date:  2009-09-24       Impact factor: 7.851
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.